About [2-[[(2S)-1-(4-methyl-3-phenoxypentan-2-yl)oxy-1-oxopropan-2-yl]carbamoyl]-3-(2-methylpropanoyloxymethoxy)-4-pyridinyl]carbamic acid
[2-[[(2S)-1-(4-methyl-3-phenoxypentan-2-yl)oxy-1-oxopropan-2-yl]carbamoyl]-3-(2-methylpropanoyloxymethoxy)-4-pyridinyl]carbamic acid (PubChem CID 175369329) has the molecular formula C27H35N3O9
and a molecular weight of 545.59 g/mol. Its IUPAC name is [2-[[(2S)-1-(4-methyl-3-phenoxypentan-2-yl)oxy-1-oxopropan-2-yl]carbamoyl]-3-(2-methylpropanoyloxymethoxy)-4-pyridinyl]carbamic acid.
Molecular Properties
| Compound Name | [2-[[(2S)-1-(4-methyl-3-phenoxypentan-2-yl)oxy-1-oxopropan-2-yl]carbamoyl]-3-(2-methylpropanoyloxymethoxy)-4-pyridinyl]carbamic acid |
| PubChem CID | 175369329 |
| Molecular Formula | C27H35N3O9 |
| Molecular Weight | 545.59 g/mol |
| Exact Mass | 545.24 |
| IUPAC Name | [2-[[(2S)-1-(4-methyl-3-phenoxypentan-2-yl)oxy-1-oxopropan-2-yl]carbamoyl]-3-(2-methylpropanoyloxymethoxy)-4-pyridinyl]carbamic acid |
| SMILES | CC(C)C(=O)OCOc1c(NC(=O)O)ccnc1C(=O)N[C@@H](C)C(=O)OC(C)C(Oc1ccccc1)C(C)C |
| InChI | InChI=1S/C27H35N3O9/c1-15(2)22(39-19-10-8-7-9-11-19)18(6)38-26(33)17(5)29-24(31)21-23(36-14-37-25(32)16(3)4)20(12-13-28-21)30-27(34)35/h7-13,15-18,22H,14H2,1-6H3,(H,28,30)(H,29,31)(H,34,35)/t17-,18?,22?/m0/s1 |
| InChIKey | CDTZWSGQQVDAMF-LYGNXSNRSA-N |
| XLogP | 3.86 |
| TPSA | 162.38 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 545.59 |
| LogP ≤ 5 | 3.86 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|
Analyze [2-[[(2S)-1-(4-methyl-3-phenoxypentan-2-yl)oxy-1-oxopropan-2-yl]carbamoyl]-3-(2-methylpropanoyloxymethoxy)-4-pyridinyl]carbamic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [2-[[(2S)-1-(4-methyl-3-phenoxypentan-2-yl)oxy-1-oxopropan-2-yl]carbamoyl]-3-(2-methylpropanoyloxymethoxy)-4-pyridinyl]carbamic acid?
The IUPAC name of [2-[[(2S)-1-(4-methyl-3-phenoxypentan-2-yl)oxy-1-oxopropan-2-yl]carbamoyl]-3-(2-methylpropanoyloxymethoxy)-4-pyridinyl]carbamic acid (CID 175369329) is [2-[[(2S)-1-(4-methyl-3-phenoxypentan-2-yl)oxy-1-oxopropan-2-yl]carbamoyl]-3-(2-methylpropanoyloxymethoxy)-4-pyridinyl]carbamic acid.
What is the SMILES notation for [2-[[(2S)-1-(4-methyl-3-phenoxypentan-2-yl)oxy-1-oxopropan-2-yl]carbamoyl]-3-(2-methylpropanoyloxymethoxy)-4-pyridinyl]carbamic acid?
The canonical SMILES for [2-[[(2S)-1-(4-methyl-3-phenoxypentan-2-yl)oxy-1-oxopropan-2-yl]carbamoyl]-3-(2-methylpropanoyloxymethoxy)-4-pyridinyl]carbamic acid is CC(C)C(=O)OCOc1c(NC(=O)O)ccnc1C(=O)N[C@@H](C)C(=O)OC(C)C(Oc1ccccc1)C(C)C.
What is the InChIKey of [2-[[(2S)-1-(4-methyl-3-phenoxypentan-2-yl)oxy-1-oxopropan-2-yl]carbamoyl]-3-(2-methylpropanoyloxymethoxy)-4-pyridinyl]carbamic acid?
The InChIKey is CDTZWSGQQVDAMF-LYGNXSNRSA-N. The full InChI is InChI=1S/C27H35N3O9/c1-15(2)22(39-19-10-8-7-9-11-19)18(6)38-26(33)17(5)29-24(31)21-23(36-14-37-25(32)16(3)4)20(12-13-28-21)30-27(34)35/h7-13,15-18,22H,14H2,1-6H3,(H,28,30)(H,29,31)(H,34,35)/t17-,18?,22?/m0/s1.
What are the key properties of [2-[[(2S)-1-(4-methyl-3-phenoxypentan-2-yl)oxy-1-oxopropan-2-yl]carbamoyl]-3-(2-methylpropanoyloxymethoxy)-4-pyridinyl]carbamic acid?
[2-[[(2S)-1-(4-methyl-3-phenoxypentan-2-yl)oxy-1-oxopropan-2-yl]carbamoyl]-3-(2-methylpropanoyloxymethoxy)-4-pyridinyl]carbamic acid has a molecular weight of 545.59 g/mol, XLogP of 3.86, 13 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[[(2S)-1-(4-methyl-3-phenoxypentan-2-yl)oxy-1-oxopropan-2-yl]carbamoyl]-3-(2-methylpropanoyloxymethoxy)-4-pyridinyl]carbamic acid is sourced from PubChem (CID 175369329), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).